A Phase 2a Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

PHASE2RecruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

July 16, 2025

Primary Completion Date

September 15, 2028

Study Completion Date

June 23, 2029

Conditions
Systemic Lupus ErythematosusActive Refractory Rheumatoid Arthritis
Interventions
DRUG

Inebilizumab

Intravenous (IV) Infusion

DRUG

Blinatumomab

SC Injection

Trial Locations (44)

1200

RECRUITING

Cliniques Universtaire Saint Luc Universite Catholique de Louvain, Brussels

3000

RECRUITING

Universitair Ziekenhuis Leuven - Campus Gasthuisberg, Leuven

4000

RECRUITING

Centre Hospitalier Universitaire de Liege - Sart Tilman, Liège

6009

RECRUITING

Linear Clinical Research Limited, Perth

9000

RECRUITING

Universitair Ziekenhuis Gent, Ghent

10154

RECRUITING

Ospedale San Giovanni Bosco, Torino

11021

RECRUITING

Northwell Health, Great Neck

13005

RECRUITING

Hopital de la Conception, Marseille

20089

RECRUITING

IRCCS Istituto Clinico Humanitas, Rozzano

20132

RECRUITING

IRCCS Ospedale San Raffaele, Milan

28041

RECRUITING

Hospital Universitario 12 de Octubre, Madrid

31059

RECRUITING

Centre Hospitalier Universitaire de Toulouse - Hopital Purpan, Toulouse

RECRUITING

Centre Hospitalier Universitaire de Toulouse - Hopital Rangueil, Toulouse

33010

TERMINATED

Vida Research Center, Hialeah

33033

TERMINATED

Homestead Associates In Research Inc, Homestead

33125

TERMINATED

Vitaly Clinical Research, Miami

39008

RECRUITING

Hospital Universitario Marques de Valdecilla, Santander

40225

RECRUITING

Universitaetsklinikum Duesseldorf AoeR, Düsseldorf

44109

RECRUITING

MetroHealth Medical Center, Cleveland

51149

RECRUITING

Krankenhaus Porz am Rhein gGmbH, Cologne

55905

RECRUITING

Mayo Clinic, Rochester

59037

RECRUITING

Centre Hospitalier Regional Universitaire de Lille - Hopital Claude Huriez, Lille

67091

RECRUITING

Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil, Strasbourg

67098

RECRUITING

Centre Hospitalier Universitaire de Strasbourg - Hopital de Hautepierre, Strasbourg

69437

RECRUITING

Centre Hospitalier Universitaire de Lyon- Hopital Edouard Herriot, Lyon

RECRUITING

Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot, Lyon Cédex 3

70112

RECRUITING

University Medical Center New Orleans, New Orleans

75014

RECRUITING

Hopital Cochin, Paris

75018

RECRUITING

Hopital Bichat Claude Bernard, Paris

75908

RECRUITING

Hopital Europeen Georges Pompidou, Paris

77054

RECRUITING

Prolato Clinical Research Center, Houston

80045

RECRUITING

University of Colorado, Aurora

80336

RECRUITING

Klinikum der LMU Muenchen, München

85258

RECRUITING

HonorHealth Research and Innovation Institute, Scottsdale

94270

RECRUITING

Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre, Le Kremlin-Bicêtre

04103

RECRUITING

Universitaetsklinikum Leipzig, Leipzig

2790-134

RECRUITING

Unidade Local de Saude de Lisboa Ocidental, EPE - Hospital Santa Cruz, Carnaxide

2600-076

RECRUITING

Unidade Local de Saude de Sao Jose, EPE - Hospital Curry Cabral, Vila Franca de Xira

4430-502

RECRUITING

Unidade Local de Saude de Gaia-Espinho, EPE, Vila Nova de Gaia

08035

RECRUITING

Hospital Universitari Vall d Hebron, Barcelona

RECRUITING

Hospital Universitari Vall d Hebron, Barcelona

08036

RECRUITING

Hospital Clinic i Provincial de Barcelona, Barcelona

CB2 0QQ

RECRUITING

Addenbrookes Hospital, Cambridge

NE7 7DN

RECRUITING

Royal Victoria Infirmary, Newcastle upon Tyne

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT06570798 - A Phase 2a Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases | Biotech Hunter | Biotech Hunter